While the primary endpoint showed numerically higher response rates with SEL-212 compared to pegloticase during months 3 and 6 combined, this difference did not reach statistical significance. 22 However, percentage reductions in serum urate levels were statistically greater with SEL-212.
← all excerpts
Biological Therapies for Urate Lowering and Inflammation Control in Gout Management.
1
—
—